Alendronate FDA Link Generic

A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.

Also Known As:

Alendronate Sodium; Fosamax; 4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate; Alendronate Monosodium Salt, Trihydrate; Aminohydroxybutane Bisphosphonate; MK-217; MK 217; MK217

Pharmalogical Action Categories:

Bone Density Conservation Agents

Organic Chemicals: 133
- Organophosphorus Compounds: 300
  - Organophosphonates: 424
    - Diphosphonates: 11565
      - Alendronate: 2711

Miki Sode Selected Research

Miki Sode Research Topics

Disease

Drug/Important Bio-Agent (IBA)